Women’s Health Still Key to Bayer Despite Early Research Shift
Exit Rumors Inaccurate
The German major has pinned its early-stage research colors to the masts of oncology, cardiovascular, neurology, rare diseases and immunology, representing a shift away from rather than an abandonment of women’s health.
